Skip to main content

Samuel M. Rubinstein

Samuel M. Rubinstein, MD, is a hematologist and medical oncologist, as well as a clinical researcher. His primary areas of clinical and research interest are plasma cell disorders such as multiple myeloma and light chain (AL) amyloidosis.

MD
Assistant Professor, Medicine-Hematology
UNC-Chapel Hill
Clinical Research

Area of Interest

I am both a hematologist and medical oncologist, as well as a clinical researcher. My primary areas of clinical and research interest are plasma cell disorders such as multiple myeloma and light chain (AL) amyloidosis. I have interests in improving our ability to predict outcomes and responses to therapy, as well as in conducting clinical trials both of therapeutics and novel supportive care approaches for patients with plasma cell disorders. I also work on ways to leverage the electronic health record to answer important clinical questions in the area of plasma cell disorders.

Awards and Honors

  • Carol O’Hare Endowed Fellowship awardee, 2019-2020
  • Travel award to attend the NCI Information Technology for Cancer Research annual PI meeting, 2019
  • JCO Clinical Cancer Informatics Reviewer Mentoring Program participant
  • Named a top 5 reviewer for JCO Clinical Cancer Informatics, 2018
  • Travel grant from the Amyloidosis Foundation to attend the 2018 American Society of Hematology meeting, 2018
  • Certificate of Completion, Resident Teaching Academy, 2017
  • F. Tremaine Billings, Jr., M.D. Award for Clinical Teaching, 2016
  • Travel grant from the Amyloidosis Foundation to attend the 2016 International Society of Amyloidosis meeting, 2016
  • Third place poster presentation, for “De Novo flare of Henoch-Schonlein purpura and IgA nephropathy in a cirrhotic”, at Regional American College of Physicians Meeting, Chattanooga, 2015
  • Member of winning team, Regional “Doctor’s Dilemma” Competition, at Regional American College of Physicians Meeting, Chattanooga, 2015

Find publications on PubMed